160 related articles for article (PubMed ID: 23425182)
1. Intravenous immune globulin in autoimmune and inflammatory diseases.
Shimoni Z; Bulvik S; Froom P
N Engl J Med; 2013 Feb; 368(8):776-7. PubMed ID: 23425182
[No Abstract] [Full Text] [Related]
2. Intravenous immune globulin in autoimmune and inflammatory diseases.
Gelfand EW
N Engl J Med; 2013 Feb; 368(8):777. PubMed ID: 23425181
[No Abstract] [Full Text] [Related]
3. Intravenous immune globulin in autoimmune and inflammatory diseases.
Gelfand EW
N Engl J Med; 2012 Nov; 367(21):2015-25. PubMed ID: 23171098
[No Abstract] [Full Text] [Related]
4. The use of intravenous immunoglobulin in autoimmune bullous diseases.
Chee SN; Murrell DF
Immunol Allergy Clin North Am; 2012 May; 32(2):323-30, viii. PubMed ID: 22560145
[TBL] [Abstract][Full Text] [Related]
5. Intravenous immunoglobulin in the treatment of autoimmune bullous dermatoses: an update.
Czernik A; Toosi S; Bystryn JC; Grando SA
Autoimmunity; 2012 Feb; 45(1):111-8. PubMed ID: 21923613
[TBL] [Abstract][Full Text] [Related]
6. Intravenous immunoglobulin in autoimmune and inflammatory dermatoses. A review of proposed mechanisms of action and therapeutic applications.
Colsky AS
Dermatol Clin; 2000 Jul; 18(3):447-57, ix. PubMed ID: 10943540
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous immunity and autoimmunity.
Alam R
Immunol Allergy Clin North Am; 2012 May; 32(2):xi-xii. PubMed ID: 22560147
[No Abstract] [Full Text] [Related]
8. High-dose intravenous immunoglobulin co-treatment prolongs time-to-treatment escalation in autoimmune bullous diseases: A monocentric retrospective cohort study.
Bertlich M; Bertlich I; Plümacher N; Hadaschik E; Enk A; Hoffmann JHO
J Eur Acad Dermatol Venereol; 2024 Jan; 38(1):e74-e76. PubMed ID: 37595621
[No Abstract] [Full Text] [Related]
9. High-dose intravenous immune globulin is also effective in linear IgA disease.
Kroiss MM; Vogt T; Landthaler M; Stolz W
Br J Dermatol; 2000 Mar; 142(3):582. PubMed ID: 10777275
[No Abstract] [Full Text] [Related]
10. [Intravenous immunoglobulins in dermatology].
Nydegger U; Hunziker T
Ann Dermatol Venereol; 2002; 129(8-9):1078-81. PubMed ID: 12442118
[No Abstract] [Full Text] [Related]
11. High-dose intravenous immunoglobulin (IVIG) therapy in autoimmune skin blistering diseases.
Ishii N; Hashimoto T; Zillikens D; Ludwig RJ
Clin Rev Allergy Immunol; 2010 Apr; 38(2-3):186-95. PubMed ID: 19557317
[TBL] [Abstract][Full Text] [Related]
12. Intravenous immunoglobulin G in the treatment of autoimmune bullous disease.
Czernik A
Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):118-9. PubMed ID: 25546786
[No Abstract] [Full Text] [Related]
13. Treatment of autoimmune blistering diseases.
Levy M; Rico MJ
Dermatol Clin; 1999 Apr; 17(2):431-40, x. PubMed ID: 10327307
[TBL] [Abstract][Full Text] [Related]
14. Practice and Educational Gaps in Blistering Disease.
Ehsani-Chimeh N; Marinkovich MP
Dermatol Clin; 2016 Jul; 34(3):251-6. PubMed ID: 27363880
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in the treatment of autoimmune mucocutaneous blistering diseases.
Ahmed AR
Int J Periodontics Restorative Dent; 2007 Aug; 27(4):309-10. PubMed ID: 17726986
[No Abstract] [Full Text] [Related]
16. Coverage of Intravenous Immunoglobulin for Autoimmune Blistering Diseases Among US Insurers.
Valdebran M; Amber KT
JAMA Dermatol; 2017 Nov; 153(11):1189-1190. PubMed ID: 28813559
[TBL] [Abstract][Full Text] [Related]
17. The use of intravenous immunoglobulin in autoimmune bullous diseases.
Chee SN; Murrell DF
Dermatol Clin; 2011 Oct; 29(4):565-70. PubMed ID: 21924999
[TBL] [Abstract][Full Text] [Related]
18. Autoimmune bullous diseases in childhood.
Sansaricq F; Stein SL; Petronic-Rosic V
Clin Dermatol; 2012; 30(1):114-27. PubMed ID: 22137235
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant drugs in autoimmune bullous diseases, efficacy versus safety: Facts and controversies.
Schiavo AL; Puca RV; Ruocco V; Ruocco E
Clin Dermatol; 2010; 28(3):337-43. PubMed ID: 20541689
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of intravenous immune globulin therapy in antibody-mediated autoimmune diseases.
Yu Z; Lennon VA
N Engl J Med; 1999 Jan; 340(3):227-8. PubMed ID: 9895405
[No Abstract] [Full Text] [Related]
[Next] [New Search]
